These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6116649)

  • 1. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM; Bartholomew TC; Jewell DP
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ; Lo Casto M
    Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H; Eisenburg J; Paumgartner G
    Eur J Clin Pharmacol; 1984; 26(4):449-51. PubMed ID: 6428914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased suppressor cell activity in inflammatory bowel disease.
    Holdstock G; Chastenay BF; Krawitt EL
    Gut; 1981 Dec; 22(12):1025-30. PubMed ID: 6119275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR; Jewell DP
    Clin Sci (Lond); 1985 Aug; 69(2):177-84. PubMed ID: 2866061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
    Molin L; Stendahl O
    Acta Med Scand; 1979; 206(6):451-7. PubMed ID: 43662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1990; 23(12):1323-34. PubMed ID: 1983789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.
    Collier HO; Francis AA; McDonald-Gibson WJ; Saeed SA
    Prostaglandins; 1976 Feb; 11(2):219-25. PubMed ID: 4854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of sulphasalazine, sulphapyridine, 5-aminosalicylic acid and prednisolone on superoxide production by human polymorphonuclear leukocytes: in vitro studies].
    Ide T
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2090. PubMed ID: 3025481
    [No Abstract]   [Full Text] [Related]  

  • 12. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?
    Aruoma OI; Wasil M; Halliwell B; Hoey BM; Butler J
    Biochem Pharmacol; 1987 Nov; 36(21):3739-42. PubMed ID: 2890355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
    Hillier K; Mason PJ; Pacheco S; Smith CL
    Br J Pharmacol; 1982 May; 76(1):157-61. PubMed ID: 6123357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine in ulcerative colitis: in memoriam?
    Hayllar J; Bjarnason I
    Gut; 1991 May; 32(5):462-3. PubMed ID: 1674925
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
    Reynolds PD; Middleton SJ; Shorthouse M; Hunter JO
    Aliment Pharmacol Ther; 1995 Oct; 9(5):491-5. PubMed ID: 8580268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR; Moore PK
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
    Eliakim R; Karmeli F; Razin E; Rachmilewitz D
    Gastroenterology; 1988 Nov; 95(5):1167-72. PubMed ID: 2901995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.
    Carlin G; Djursäter R; Smedegård G
    Ann Rheum Dis; 1992 Nov; 51(11):1230-6. PubMed ID: 1361317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Miyachi Y; Yoshioka A; Imamura S; Niwa Y
    Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.